Latest Updates of Companies in the Latin America Pharmaceutical Contract Manufacturing and Research Services Market
Market Ecosystem Analysis
| Ecosystem Segment | Description | Representative Participants |
| Technology Providers | Manufacturing technologies, bioprocessing systems, analytical platforms | Lonza, West Pharmaceutical Services |
| Product Manufacturers (CDMOs/CMOs) | API and finished-dose manufacturing services | Catalent, Recipharm, Thermo Fisher Scientific Patheon |
| CRO Service Providers | Clinical trials, laboratory and regulatory services | IQVIA, Labcorp Drug Development, Charles River Laboratories |
| Platform Providers | End-to-end development and commercialization platforms | Thermo Fisher Scientific, Lonza |
| CROs/CDMOs | Integrated research and manufacturing outsourcing organizations | Lonza, Catalent, Thermo Fisher Patheon, Recipharm, Charles River |
| Software Vendors | Clinical trial and data management platforms | IQVIA, Medpace, Oracle Health Sciences |
| Research Institutions | Clinical trial networks and translational research centers | Fiocruz, Instituto Butantan |
| End-User Industries | Pharma, biotech, biosimilars, vaccines, specialty therapeutics | Global pharma, regional pharma, biotech startups |
Recent Developments in the Market
- In May 2026, Bayer aims to expand its consumer health business in Brazil to twice its current size within the next five years. To support this growth, the company is evaluating the possibility of setting up a local manufacturing facility if the strong momentum achieved in recent years continues. The consumer health portfolio includes over-the-counter medications, self-care solutions, and preventive healthcare products. Key brands such as Bepantol and Gino-Canesten generate approximately 70% of the division’s total revenue in the Brazilian market.
- In April 2026, the Brazilian Health Regulatory Agency (Anvisa) welcomed a delegation from Mexico to strengthen collaboration between the two countries in the healthcare sector. During the meeting, Mexico’s Federal Commission for Protection against Health Risks (COFEPRIS) officially ratified the Rio de Janeiro Declaration. The discussions also focused on sharing regulatory expertise, advancing healthcare innovation, and exploring ways to streamline product evaluation processes to improve efficiency and accelerate access to healthcare products.
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Lonza | Basel | Switzerland | One of the world's largest CDMOs serving multinational pharma and biotech clients across Latin America | Biologics manufacturing, API production, formulation development |
| Catalent | Somerset, New Jersey | USA | Major provider of drug development and commercial manufacturing services | Drug development, biologics, oral solids, clinical supply |
| IQVIA | Durham, North Carolina | USA | Dominant CRO with extensive Latin American clinical trial operations | Clinical trials, real-world evidence, regulatory support |
| Thermo Fisher Scientific | Waltham, Massachusetts | USA | Patheon business is among the largest integrated CDMOs globally | API manufacturing, sterile fill-finish, development services |
| Charles River Laboratories | Wilmington, Massachusetts | USA | Leading preclinical and research outsourcing organization | Drug discovery, toxicology, preclinical research |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Recipharm | Stockholm | Sweden | Strong European CDMO expanding support for multinational clients in Latin America | Formulation, manufacturing, packaging |
| Labcorp | Burlington, North Carolina | USA | Significant CRO operations and clinical trial support in the region | Clinical development, laboratory services |
| Unither Pharmaceuticals | Amiens | France | Specialized contract manufacturing provider with global customer base | Sterile unit-dose manufacturing |
| West Pharmaceutical Services | Exton, Pennsylvania | USA | Critical supplier supporting pharmaceutical manufacturing ecosystem | Packaging, containment, delivery systems |
| Boehringer Ingelheim BioXcellence | Ingelheim am Rhein | Germany | Global biologics manufacturing partner serving multinational clients | Biologics CDMO services |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Eurofarma | São Paulo | Brazil | Regional manufacturing leader with contract production capabilities | Finished-dose manufacturing, generics |
| Cristália | Itapira, São Paulo | Brazil | Significant API and specialty manufacturing infrastructure | APIs, injectables, contract manufacturing |
| EMS Pharma | Hortolândia, São Paulo | Brazil | Large-scale pharmaceutical manufacturing platform | Oral solids, generics manufacturing |
| Laboratorios Richmond | Buenos Aires | Argentina | Expanding biologics and vaccine manufacturing capabilities | Biologics, sterile manufacturing |
| Blau Farmacêutica | Cotia, São Paulo | Brazil | Growing biologics and injectable manufacturing presence | Injectable drugs, biosimilars |
Market Growth
The Latin America pharmaceutical contract manufacturing and research services market size stood at US$ 22.53 billion in 2025, grew to US$ 24.09 billion in 2026, and is forecast to reach US$ 43.99 billion by 2035, expanding at a CAGR of 6.92% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking